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Abstract: The aim of the study is to evaluate, in a ligature-induced periodontitis model, the efficacy of
a commercially available dental resin containing different antimicrobial glass/glass-ceramic additions
(0–26 wt.%). It has been proved that a 26 wt.% glass addition to a conventional dental resin matrix
does not alter neither its workability nor its adhesion to the surface of teeth; however, it does
confer notable antimicrobial properties when tested in vitro. Moreover, in vivo tests in Beagle dogs
demonstrated the prevention of bone loss in ligature-induced plaque accumulation around teeth.
Particularly, the glass-ceramic filler resin composite has shown excellent antimicrobial control since
it displays the same bone loss as that of the negative control. The results obtained in the present
investigation have shown that a conventional dental resin containing a fraction of glass/glass-ceramic
(≥26 wt.%) can prevent periodontitis, which is considered to be a most serious dental disease.
Keywords: periodontitis; bactericidal glass/glass-ceramic; dental materials; dental composites
1. Introduction
Within the past few years, the rates of periodontal and peri-implant disease have increased
exponentially, boosted by population ageing, chronic diseases and people’s current lifestyle
(stress, obesity, bad habits, etc.). Periodontal diseases include gingivitis and periodontitis which
are infectious diseases in nature. In developed countries, about 60% of people over 30 suffer from
this condition, which represents the main cause of tooth loss in adult patients. Furthermore, there is
growing evidence of a possible association between periodontitis and various systemic diseases
and conditions such as respiratory disease, chronic kidney disease, rheumatoid arthritis, cognitive
impairment, adverse pregnancy outcomes, obesity, metabolic syndrome and cancer [1]. Preventing the
progression of these serious health concerns is thus of critical importance.
It may be difficult to comprehend how to prevent and treat periodontal diseases without
knowledge of the key-stone role of bacterial plaque. Since Silness et al. [2] proved the relationship
between oral bacteria and gingivitis, the concept of the role of bacteria in periodontal disease
etiology has evolved from the “specific and nonspecific plaque hypothesis” [3] to the concept of
the opportunistic or ecological nature of periodontal microbiota [4]. Today we know that many
of the microorganisms involved in periodontal diseases are uncultivable but identifiable through
advanced nucleic acid probe technologies. They make up the periodontitis-associated microbiota
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and are organized in microbial clusters which have the potential to disrupt host defenses and induce
an immune reaction that ultimately leads to soft and hard periodontal tissue breakdown.
Traditional methods of periodontal prevention and treatment are based on bacterial control by
mechanical removal. Dental scaling and root planning aim to remove supragingival and subgingival
calcified deposits, to reduce subgingival biofilm and also to detach and eliminate loosely bound
endotoxin from root surfaces, thus restoring sufficient biocompatibility to facilitate healing by the
formation of a long junctional epithelium [5]. However, the mechanical treatment of periodontal
disease, whether surgical or non-surgical, is limited principally by its inability to completely
eliminate pathogenic bacteria from the periodontal tissues, thereby affecting a sustained shift towards
a nonpathogenic subgingival microflora. As a consequence, recolonization of treated periodontal
sites by pathogenic bacteria following root-surface debridement is associated with poorer therapeutic
outcomes. The principal sources of re-infection are endogenous and include the sequestration of
organisms within the residual biofilm at poorly accessible sites, such as furcation and within root
grooves, invasion of epithelial cells by certain pathogens and recolonization of periodontal sites from
other oral niches [6]. As a matter of fact, there is insufficient evidence to determine the effects of routine
scale and polish treatments [7].
The aforementioned limitations prompted the use of antimicrobial drugs as adjunctive chemical
methods for eliminating periodontal bacteria. However, most local antimicrobial delivery systems
have had limited success because of the lack of substantivity from sustained-release devices and their
tendency to facilitate bacterial resistance. On the other hand, the use of systemic antibiotics remains
highly controversial, except in the management of aggressive periodontitis, as a result of issues related
to its ecological impact on microbiome [8,9]. However, due to the importance of bacterial control in
periodontal disease treatment, novel adjunctive antimicrobial approaches have emerged within the
scientific and clinical literature in recent years. These include photodynamic therapy, prebiotics and
probiotics, and the “one-stage full-mouth disinfection” clinical approach [10,11]. However, the long
term efficacy of these approaches remains unclear. In this regard and attending to the emerging
importance of bioactive glasses as antimicrobials, we have explored the role of new bioactive glasses
in the prevention of periodontal disease in an in vivo experimental study.
For research purposes, the ligature model has been extensively used in preclinical studies on
experimental periodontitis to promote tissue breakdown in a short period of time [12]. The placement
of a ligature in a subgingival position disrupts the soft tissue seal around teeth and implants and opens
the pocket for biofilm formation. While a ligature made of cotton or silk may not induce bone loss by
itself, the developing inflammatory process in the connective tissue that results from biofilm formation
mediates tissue destruction during the experiment [13].
A new generation of inorganic biocides based on CaO-enriched soda-lime glasses and ZnO-rich
glasses has been recently developed [14,15]. These glasses are suitable for application in several
strategic fields in which the control of an unwanted heterogeneous microbial population represents
a serious threat to human health. The efficacy of a coating made of this kind of glasses to prevent
peri-implant diseases was recently pointed out in a previous in vivo research study [16].
Furthermore, in our previous works [17–19], a new glass-ceramic composed of combeite and
nepheline in a residual soda-lime glassy matrix was fabricated by sintering at 750 ◦C for 1 h.
The antibacterial activity of this glass-ceramic, free of P2O5, effectively diminishes the growth
(logarithm of reduction >3) of bacteria (such as S. aureus, E. coli, S. epidermidis, M. lutea, and
P. aeruginosa) [17] as well as yeast (C. krusei) [18]. It has also been shown that this glass-ceramic
inhibits adhesion and biofilm formation [17]. Furthermore, in vitro biocompatibility assays with
human stem cells demonstrated that the new glass-ceramic also shows excellent biocompatibility [17].
The main objective of the present work is to study the influence of an antimicrobial
glass/glass-ceramic addition, similar to the ones mentioned before, to a flowable resin composite.
The addition of a glass-ceramic or a particulate glass containing a high ZnO fraction to a conventional
dental polymer composite can play and important role in preventing periodontitis. To this end,
Coatings 2018, 8, 259 3 of 12
in vivo experiments have been carried out on Beagle dog fangs subjected to a ligature-induced
periodontitis model.
2. Materials and Methods
2.1. Glass/Glass-Ceramic Synthesis and Characterization
A glass and glass-ceramic were prepared in a similar way to that previously described by the
authors [14,15,17]. Briefly, a glass powder from the SiO2–Na2O–Al2O3–CaO–B2O3 system with the
following chemical composition was used (wt.%): 41.6 SiO2, 20.0 Na2O, 19.5 CaO, 10.1 Al2O3, 6.4 B2O3,
0.21 MgO, and 0.61 K2O (Nanoker Research, Oviedo, Spain). The precursor powder was thermally
treated in a conventional furnace in air at 750 ◦C for 1 h at a heating rate of 5 ◦C/min leading to
glass-ceramic material. After thermal treatment, the powders were ground in an alumina mortar
and subsequently sieved through a <40 µm mesh. The average particle size obtained, as measured
using a laser technique (LS Particle Size Analyzer 13 320, Beckman Coulter, Indianapolis, IN, USA),
was found to be d50 = 10.30 ± 0.55 µm (Table 1). This glass-ceramic was labelled as G3-GC.
Table 1. Particles size distributions (in volume percentages) of G3-GC and 35ZnO-G. d10, d25, d50, d75,
d90: particle diameters corresponding respectively to 10%, 25%, 50%, 75%, and 90% of the cumulative
size distribution curve.
Sample d10 (µm) d25 (µm) d50 (µm) d75 (µm) d90 (µm)
G3-GC 4.29 6.08 10.30 26.75 37.27
35ZnO-G 1.93 4.73 7.53 10.39 12.77
A zinc-containing glass, belonging to the B2O3–SiO2–Na2O–Al2O3–ZnO system, and with the
following chemical composition (wt.%): 19.39 SiO2; 34.24 B2O3; 5.55 Na2O; 5.13 Al2O3 and 34.73 ZnO
was prepared by fusion of mixtures of Na2CO3, SiO2, B2O3, ZnO and Al2O3 in Pt crucibles at 1250 ◦C
for 1 h in an electric furnace. After melting, it was quenched by dipping the crucible into water,
dried, grinded in an alumina mortar and sieved down to 40 µm. The average particle size (Beckman
Coulter LS Particle Size Analyzer 13 320) was found to be d50 = 7.53 ± 0.1 µm (Table 1). This glass
powder was labelled as 35ZnO-G.
2.2. Composite Synthesis and Characterization
A commercially available flowable dental composite FiltekTM Supreme XTE Flowable Restorative
(3M ESPE, St. Paul, MN, USA) was reinforced with varying amounts of the antimicrobial
glass/glass-ceramic (0, 13, 26 wt.%). This resin, according to its manufacturer, contains: bis-GMA,
TEGDMA and Procrylat resins and the inorganic filler loading is approximately 65% by weight
(46% by volume).
Plates of dimensions 1.5 cm× 1.5 cm were prepared by homogeneously mixing the resin composite
with 13, 26 wt.% of glass/glass-ceramic powders. Light curing was performed according to the
manufacturers’ instructions. Photopolymerization was performed using a curing lamp (BA optimal 10,
B.A International, Kingsthorpe, UK). The glass-ceramic or glass composites were labelled as G3-GC13,
G3-GC26, 35ZnO-G13, 35ZnO-G26.
The obtained composite was analyzed by means of FESEM and EDS analysis to evaluate
the homogeneity of particle dispersion. The analyses were performed both on sample surfaces
and cross-sections. For cross-section evaluation, the composites were cut with a cut-off machine
(TM3-A Boccadoro, Losone, Switzerland) and subsequently polished down to 1 µm.
2.3. In Vitro Antibacterial Test
Previous to the in vivo test, the bactericidal efficacy of the resin composites was evaluated
according to ISO 22196:2011 [20]. This standard specifies a method of evaluating the antibacterial
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activity of antibacterial treated plastics and other non-porous product surfaces. ISO 22196:2011
recommends using Staphylococcus aureus (ATCC 6538P) and Escherichia coli (ATCC 8739) bacterial
species for the bactericidal capability test. The analysis was performed in triplicate. For each
microorganism, 3 specimens of the untreated material (control) were used to measure viable cells
immediately after inoculation and another 3 specimens of the untreated material (control) were used
to measure viable cells after 24 h of incubation. 3 specimens of each treated test material were used to
measure viable cells after 24 h of incubation.
The square test composites (1.5 cm × 1.5 cm): 6 untreated resins and 3 filled with
glass/glass-ceramic composites were placed in petri dishes and inoculated with 50 µL of the test
inoculum (containing 2.7 × 105 CFU/mL of Escherichia coli or 4.5 × 105 CFU/mL of Staphylococcus
aureus). The inoculum was covered with a sterile polyethylene coverslip (1.4 cm× 1.4 cm), which allows
the inoculum to spread well, prevents it from drying and ensures good contact with the antimicrobial
surface. Immediately after inoculation, half of the untreated composites were supplied with 5 mL
of phosphate-buffer saline to recover bacteria from the surface of the specimens. The recovered
bacteria cell suspension was then serially diluted in physiological saline. Petri dishes containing plate
count agar were inoculated with these recovered bacterial dilutions in duplicate. These plates were
incubated for 24–48 h at 37 ◦C, after which CFU were determined. The remaining 3 untreated and
glass/glass-ceramic composites were incubated for 24 h at 37 ◦C and 95% humidity. After this time,
the bacterial cells were recovered from the surface and the number of microorganisms present on the
surfaces was determined in the way previously described. The reduction in microorganisms in relation
to the initial concentrations and the control surface was calculated. Antibacterial activity, delineated as
R, was calculated following Equation:
R = (Ut −U0)− (At −U0) = Ut − At
where R is antibacterial activity; U0 is the average logarithm of the number of viable bacteria,
in cells/cm2, recovered from untreated test specimens immediately after inoculation; Ut is the average
logarithm of the number of viable bacteria, in cells/cm2, recovered from untreated test specimens after
24 h; and At is the average logarithm of the number of viable bacteria, in cell/cm2, recovered from
treated test specimens after 24 h.
Converting logarithmic (base 10) reduction R to percentage reduction (P) is possible applying
the following formula: P = 100 × (1 − 10−R). This means that the R-values (log10 scale) of 1, 2,
3, 4, 5 and 6 correspond to microbial load reductions of 90%, 99%, 99.9%, 99.99%, 99.999% and
99.9999%, respectively.
2.4. In Vivo Test
2.4.1. Animals
This study was carried out in strict accordance with Directive 2010/63/EU on the protection
of animals used for scientific purposes. The protocol was approved by the Ethics Committee for
Animal Research Welfare of the Minimally Invasive Surgery Center (Cáceres, Spain). Five Beagle
dogs were used in this experiment to meet the goal of reduction, the second of the 3R’s (Replacement,
Reduction and Refinement), a widely accepted ethical framework for conducting scientific experiments.
In addition, it is common practice to employ this number of animals for such experiments and thus
satisfy statistical power requirements. At the initiation of the experiment, the dogs were 5 years old
and weighed 19 kg on average.
During all procedures, veterinary assistance was used continuously and all efforts were made to
minimize suffering. General anaesthesia was induced with intravenous injected propofol 10 mg/kg
(Propofol Hospira, Hospira Productos Farmacéuticos y Hospitalarios, Madrid, Spain). One no. 7
endotracheal tube with a balloon cuff was placed and connected to a circular anesthesia circuit (Leon
Plus, Heinen & Löwenstein, Bad Ems, Germany). The anesthesia was sustained with sevofluorane
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(Sevorane, Abbott Laboratories, Madrid, Spain). Multimodal analgesia was employed in the
perioperatory [ketorolac 1 mg/kg (Toradol 30 mg, Roche, Basel, Seitzerland), tramadol 1.7 mg/kg
(Adolonta inyec., Grünenthal, Aachen, Germany) and buprenorfine 0.01 mg/kg (Buprex, Reckitt
Benckiser Pharmaceuticals Limited, Berkshire, UK)].
2.4.2. Dental Preparations
Sample size was 20 canines (5 dogs) but the study unit was each aspect (medial and distal)
of each fang. Negative controls were used to exclude spontaneous bone loss or recession due to
any etiology unrelated with the experiments. Negative controls consisted of 2 canines (4 aspects)
without intervention (no class V obturation nor periodontitis ligature induction). Class V dental
preparations (named CV) (Black’s classification) were performed in 18 canines (36 aspects) using
a 0.5 mm diameter drill bur (Komet Dental, Lemgo, Germany) and affecting the enamel next to the
supra gingival margin all the way around the neck of the crown (Figure 1a). Dental preparations
were conditioned by a self-etching one-step primer and bonding solution (3M ESPE ScotchBond
Universal Adhesive, St. Paul, MN, USA) that was light-cured for 20 s (BA optimal 10, B.A International,
Kingsthorpe, UK). Consecutively, these preparations were filled with different restorative materials.
A universal restorative dental composite (3M ESPE Filtek Supreme XTE, St. Paul, MN, USA) was
used as the control material (n = 6, 12 aspects). In the test branches (for each group n = 6, 12 aspects),
G3-GC or 35ZnO-G powders were mixed (26 wt.%) with the commercial dental composite to provide
them with antimicrobial properties, as previously described. The mixing was performed by hand
with a stainless steel dental cement spatula on a glass slab. Dental materials were randomly allocated.
All preparations were filled via incremental addition using a dental spatula (Dental Spatula XTS
Composite No 03 Flexi Thin, Hu-Friedy Mfg Co., Chicago, IL, USA) and light-cured.
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Figure 1. (a) Class V dental preparation of Beagle dogs canines; (b) Traditional ligature to
induce periodontitis.
2.4.3. Experimental Periodontitis
The tra itional ligature model was used to induce acut breakdown of periodontal tissues as
described by Lindhe et al. in 1973 [12]. Dental preparations were overfilled to provide retention for
ligatures since canines have a conical shape and ligatures tend to slip off and to be loose. Ligatures
were placed in a yuxtagingival position and no plaque control procedures were performed (Figure 1b).
2.4.4. Bone Loss M a urements
After 8 weeks of ligature periodontitis induction the animals were euthanized with a lethal
dose of Sodium-Pentothal. Blocks containing the canines were retrieved from the jaw bone using
an oscillating autopsy saw (Exakt, Kulzer, Germany). The dissected specimens were sent to two
blinded appraisers who measure the medial and distal aspects of the canines, to assess the distance
between th apical portion of th dental restoration and he res dual margin l bo e level. Distance
Coatings 2018, 8, 259 6 of 12
was assessed using a double-pointed compass (EMI Deluxe EKG Caliper, Fullerton, CA, USA) as can
be observed in Figure 2. A trained program was implemented to increase inter- and intra-examiner
reliability. Mean values for all variables were calculated for the mesial and distal aspect of each
tooth. Comparisons were made using absolute values (final bone loss in millimeters). Differences
were analyzed using a non-parametric (Mann-Whitney) method. The null hypothesis was rejected
at p ≤ 0.05.Coatings 2018, 8, x FOR PEER REVIEW  6 of 12 
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Figure 2. Images of specimens during measurements procedures in teeth with class V obturations with
different materials: (a) Commercial dental composite (positive control); (b) Dental composite filled
with 26 wt.% of G3-GC powder; (c) Dental composite filled with 26 wt.% of 35ZnO-G powder.
The cross-sections of the dissected specimens, after polishing (<1 µm), and their corresponding
external surfaces were also characterized by Field Emission Scanning Electron Microscopy (FESEM)
(FEI: Quanta FEG 650, Hillsboro, OR, USA) and Energy Dispersive Spectroscopy (EDS) equipment
from EDAX-AMETEK GmbH (Meerbusch, Germany).
3. Results
3.1. Starting Material Characterization
According to the manufacturer’s general information, the fillers are a combination of
ytterbium trifluoride with a particle size r nge of 0.1 to 5 µm, a non-agglom rated/non-aggregated
surface-modified 75 nm silica filler and a surface-modified aggregated zirc nia/silica cluster filler
(comprised of 20 nm silica and 4 to 11 nm zirconia ticle ). The aggregate has an average
cluster particle size ranging from 0.6 to 10 µm (Figure 3a). In Figure 3b,c the FESEM micrographs
corresponding to G3-GC26 and 35ZnO-G26 resin composites are shown. The particle size distributions
of both powders are shown in Table 1.
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Figure 3. Scanning electron micrographs of the polished cross-sectioned control composite (a) and the
corresponding EDS analysis; co posite containing G3-GC26 (b) and the corresponding EDS analysis
of the G3-GC particles; composite containing 35ZnO-G26 (c) and the corresponding EDS analysis of
the 35ZnO-G particles.
3.2. In Vitro Results
Composites containing G3-GC and 35ZnO-G showed bactericidal efficacy against the evaluated
bacteria (Table 2). Both glasses exhibit dose-dependent killing. The higher the glass content, the higher
the bactericidal activity. They were more active ag inst Gram negative bacteria (99.9% f reduction for
E. coli vs. 99% of reduction for S. aureus).
Table 2. In vitro antimicrobial activity: Ut is the average of the common logarithm of the number of
viable bacteria, in cell/cm2, recovered from the untreated test specimens after 24 h; At is the average of
the common logarithm of the number of viable bacteria, in cell/cm2, recovered from the treated test
specimens after 24 h. R is the antibacterial activity. R = Ut − At.
Sample
E. coli S. aureus
Ut At R Ut At R
G3-GC13 4.21 2.07 2.14 3.20 2.08 1.12
G3-GC26 4.21 0.70 3.51 3.20 1.41 1.80
35ZnO-G13 4.21 0.77 3.44 3.20 0.35 2.85
35ZnO-G26 4.21 0.35 3.86 3.20 0.35 2.85
3.3. In Vivo Results
Taking the dose-dependent killing into account, in vivo tests were only carried out using resins
with the highest content of glass/glass-ceramic (i.e., 26 wt.%).
No bone loss was detected at the end of the experiment around negative control teeth. The mean
amount of bone loss that occurred at the end of the ligature-induced periodontitis period was found to
be 0.92 mm around positive control teeth; 0 mm around teeth filled with a dental composite containing
G3-GC26 powder and 0.33 mm around teeth filled with a dental composite containing 35ZnO-G26
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(Table 3). There are significant differences in bone loss between positive controls and G3-GC26 filled
teeth (p = 0.045 Mann-Whitney) but no statistical differences were found between the controls and
35ZnO-G26 filled teeth (p = 0.217 Mann-Whitney). Inter-appraiser and intra-appraiser agreement
turned out in Kappa values of 0.84 and 0.92, respectively.
Table 3. Mean values of bone loss at distal and mesial aspect of teeth filled with different restorative
materials in Class V preparations.
Sample n Mean SD Mann-Whitney
Control 12 0.92 1.24 –
G3-GC26 12 0 0 0.045
35ZnO-G26 12 0.33 0.49 0.217
3.4. Composite Characterization
The FESEM micrographs corresponding to the external surface of the composite toroid (Figure 4)
show that, in both cases (i.e., G3-GC26 and 35ZnO-G26 composites), grains >10 µm have been
pulled-out leaving a gap. In the case of both filled composites, the grains subjected to continuous
abrasion in the dog’s mouth and some cracks, probably produced by pull-out (identified with
white arrows in Figure 4), are still clearly visible. In the particular case of G3-GC26, almost all
grains <10 µm (~50% of the volume fraction) have remained, resisting the wear of the dog’s tongue
without an appreciable dissolution effect (Figure 4a). The dissolution of the grains is more significant
in the case of 35ZnO-G26 composites (Figure 4b). Footprints clearly correspond to a sharp contour of
the particles.
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4. Discussion
Diverse research with different additives has been carried out to develop effective antibacterial
resin-based composites. Most of these additives are organic bactericides, such as: quaternary
ammonium dimethacrylate (QADM) [21], dimethylaminohexadecyl methacrylates (DMAHDM) [22],
dimethyl-hexadecylmethacryloxyethyl-ammonium iodide (DHMAI) [23], quaternary ammonium
polyethylenimine (PEI) nanoparticles [24], chlorhexidine [25], triclosan [26] or chitosan [27]. Inorganic
coatings have emerged as an alternative approach since they present several advantages compared
to traditional organic agents, which include chemical stability, thermal resistance and protracted
action, and they have not yet been associated with resistant organisms [28]. Silver is the most
studied antibacterial metal ion for the treatment of periodontitis and perimplantitis [29]. The use of
different experimental fillers is another important strategy. In this sense, multifunctional bioactive
glasses and glass-ceramics could be an alternative antimicrobial system. The bioactivity of the
glass/glass-ceramic has made the current composite an interesting candidate for potential applications
in the dental field. Tauböck et al. functionalized a dentin bonding resin with 20 wt.% ultrafine
SiO2-Na2O-CaO-P2O5-Bi2O3 particles. This bioactive glass loading does not influence microhardness,
and the viscosity of the composite remained below that of a flowable dental composite [30]. However,
it did not evaluate the possibility of conferring antimicrobial properties to the dental resin, at least
to the author’s knowledge. Khvostenko et al. investigated the effect of adding 15 wt.% bioglass
(65% SiO2-31% CaO-4% P2O5 (mol.%)) to a resin composite on bacterial biofilms penetrating into
marginal gaps of simulated tooth fillings in vitro during cyclic mechanical loading. A significantly
lower degree of bacterial biofilm penetration into the gap was found [31]. The results obtained in the
present in vivo experiment, although limited by sample size, due to the ethical issues involved in the
use of Beagle dogs in in vivo experiments, demonstrate the antimicrobial performance of a dental
resin matrix containing different bioglass fillers and can thus expand the clinical applications of these
materials in the treatment of dental diseases in the near future.
It has been proven that the concentration required to obtain the desired antimicrobial properties
(26 wt.%) does not compromise tooth-bonding efficacy nor workability. The dental adhesive remained
on the tooth until the end of the in vivo test (Figure 2). Further studies are ongoing in order to complete
the mechanical characterization.
It is important to point out that both powders display a different particle size distribution as
is made clear in Table 1. The G3-GC26 powder has a larger average grain size (d50 = 10.3 µm) and
course fraction than the Zn-containing glass (d50 = 7.5 µm). Particle distribution was found to be very
homogeneous in both cases and no aggregates are observed in the polymer matrix (Figure 3).
Although the bactericidal properties of these glasses have been extensively proved [14,17], in vitro
tests were carried out before the in vivo test to ensure that the composites preserve their efficacy.
In agreement with the results obtained in vitro, the in vivo tests were performed using the composites
containing 26 wt.% glass or glass-ceramic particulate filler.
At 24 h, time at which the in vitro tests were carried out according to the standard, the composite
reinforced with 35ZnO-G26 looks more active than the one containing G3-GC26. This trend can be
explained taking into account the different dissolution behavior of the glasses. However, after 72 h,
both materials show the same antimicrobial performance [14,17]. Due to differences in microbiological
test protocols, previous results obtained by other authors cannot be directly compared to one another
or to the results of the present study.
In the FESEM micrographs corresponding to the external surface of the composite toroid (Figure 4),
after the in vivo test, we can observe that, in both cases (G3-GC26 and 35ZnO-G26 glass composites),
grains >10 µm have been pulled-out leaving a gap. In the particular case of the G3-GC26 glass-ceramic,
almost all grains <10 µm (~50% of the volume fraction) have remained, resisting the wear of the dog’s
tongue without an appreciable dissolution effect (Figure 4a). As observed in Figure 3, two crystalline
phases precipitate during G3-GC powder annealing at 750 ◦C: nepheline (Na6.65Al6.24Si9.76O32) and
combeite (Na2Ca2Si3O9). In a previous study [17], nepheline crystals were described as elongated
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(>10 µm) while combeite crystals were found to be equiaxed and much smaller (<50 nm). The presence
of nepheline needle-like crystals drastically improves the wear resistance of this composite. This fact
can explain its good behavior in the prevention of the induced periodontitis (Table 3). Therefore, its
antimicrobial activity is not significantly affected during the 4 months of testing in the dog’s mouth.
Conversely, in the case of the Zn-containing glass composite, 35ZnO-G shows the typical XRD
pattern of a perfect glass [14]. Taking into account that its granulometric distribution is noticeably
narrower than that corresponding to G3-GC and that it is more soluble, the majority of the grains
<5 µm (~25% of the volume fraction) were dissolved as a consequence of the continuous abrasion to
which it is subjected inside the dog’s mouth. It is, therefore, logical to think that the biocidal activity
of this composite has been significantly reduced and was most probably limited to the first weeks of
implantation. Nevertheless, statistical results (p = 0.217) tend to be significant and suggest that with
a larger number of subjects more relevant differences might be detected in terms of bone loss between
35ZnO-G and positive control groups.
Since negative controls did not experience any bone loss during the experiment, it can be
assumed that the bone loss achieved around positive controls and cases is totally due to experimental
ligature-induced periodontitis.
5. Conclusions
It has been proved that a 26 wt.% glass addition to a conventional dental resin matrix does not
alter either its workability or its adhesion to the surface of teeth; however, it does confer notable
antimicrobial properties when tested in vitro. This performance results in an in vivo prevention of
bone loss when plaque accumulation is induced by ligature around the teeth. Particularly, G3-GC26 has
shown excellent antimicrobial control since it displays the same bone loss as that of the negative control
and prevents bone loss (p = 0.045) with respect to the positive control. 35Zn-G26 has shown an excellent
in vitro behavior; however, in vivo, it might be affected by the dissolution rate of its glass particles.
Statistical results indicate that further experiments with larger sample sizes and a bigger average
particle size might display a resounding result. Finally, the results obtained in the present investigation
have shown that a conventional dental resin containing a fraction of these glasses (≥26 wt.%) can
prevent periodontitis, which is considered to be a most serious dental disease.
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